PHC Holdings Corporation

About Us

About PHC Group CEO Message Mission, Vision & Values Value Creation Plan History Leadership PHC Group by the Numbers

Group Companies

Ascensia LSI Medience Wemex Mediford Epredia PHCbi PHC IVD

Products & Services

Cancer Pathology Biologic & Cell Preservation Diagnostic Testing Patient Record & Billing Software Diabetes Management Medical Device & Drug Delivery

Sustainability

Investor Relations

INVESTOR RELATIONS

MANAGEMENT

IR LIBRARY

STOCK INFORMATION

IR News Financial Highlights IR Calendar Contact IR Disclaimer

Newsroom

NEWSROOM

NEWS

Careers Contact

JP

Other PHC Group Websites

Other PHC Group Websites

Careers Contact JP

News

2025

Select year
- All view
- 2025
- 2024
- 2023
- 2022
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
- 2015

PHC
Holdings Corporation
Group Companies

Aug.7 IR: Notice on Recording of Financial Expenses (Foreign Exchange Losses)

Aug.1 Announcement: PHC Group Achieves Group 1 Rating in Morningstar Japan ex-REIT Gender Diversity Tilt Index

Jun.25 News: Announcement of Board Members at PHC Holdings Corporation Effective June 25, 2025

Jun.25 IR: Grant of units to officers and employees of the Company and subsidiaries under post-vesting performance-linked and fixed stock remuneration plans

Jun.25 News: PHC Group Targets on Greenhouse Gas Reduction Validated By Science Based Targets Initiative

Jun.23 Announcement: Notice Regarding the Relocation of LSI Medience Corporation Headquarters in Tokyo

Jun.16 IR: Completion of payment for issuance of new shares based on Performance Share Units (PSUs) and Restricted Stock Units (RSUs) and partial changes

Jun.13 IR: Matters Concerning Controlling Shareholders, etc.

May.28 IR: Grant of units to officers and employees of the Company and subsidiaries under post-vesting performance-linked and fixed stock remuneration plans

May.28 IR: Amendment to post-vesting performance-linked and fixed stock remuneration plans (Proposal for resolution at annual general meeting of shareholders)

May.28 IR: Notice regarding issuance of new shares based on Performance Share Units (PSUs) and Restricted Stock Units (RSUs)

May.28 News: Announcement of Changes of Corporate Officers at PHC Holdings Corporation Effective June 25, 2025

May.13 Announcement: Stakeholder Engagement Map Now Available on PHC Group Website

Mar.31 Announcement: PHC Group Announces Completion of Third-party Verification of Greenhouse Gas Emissions and Water Use Data

Feb.28 IR: Notice on New Board Members

Feb.6 IR: Notice Concerning Submission of Report on the Completion of Response to the Public Health Center regarding the Inappropriate Quality Management at LSI Medience Corporation, a Subsidiary of PHC Holdings Corporation

Jan.15 News: PHC Group CEO Kyoko Deguchi Named a Top 50 Healthcare Technology CEO of 2024 by The Healthcare Technology Report

Jan.8 News: Announcement of Changes of Corporate Officers at PHC Holdings Corporation Effective March 31, April 1, 2025

Aug.29 NewsPHCbi: PHC Corporation’s Biomedical Division Wins 2025 R&D 100 Award for LiCellMo® Live Cell Metabolic Analyzer

Jul.1 ProductsPHCbi: PHC Announces Exclusive Distribution of MaxCyte® ExPERT™ Platform in Japan – Enabling Scalable, Non-Viral Cell Engineering for Research, Biomanufacturing, and Therapeutic Development -

May.8 NewsAscensia: Eversense 365 Recognized for Diabetes Management Innovation in 2025 MedTech Breakthrough Awards

Apr.4 NewsAscensia: Eversense 365 Wins Gold at 2025 Edison Best New Product Awards

Mar.19 NewsPHCbi: PHC and Cyfuse Develop Innovative Production Technology for the Commercialization of 3D Cell Products

Mar.5 NewsEpredia: Epredia Receives U.S. FDA 510(K) Clearance for the E1000 Dx^™ Digital Pathology Solution Designed to Improve Laboratory Workflow in Cancer Diagnostics

Mar.3 NewsPHCbi: PHC Launches Next-Generation CO2 Incubator Combining Advanced Antimicrobial Technology with Eco-Conscious Design

Feb.10 NewsPHCbi: PHC and CCRM Collaborate to Develop Primary T-Cell Expansion Culture Processes to Enhance Efficiency and Improve Cell Quality